Do you want to read an article? Please log in or register.
Photodynamic therapy for the treatment of atherosclerotic plaque: lost in translation?
Related content
COMMENTED
Heart, Artery and Coronary Diseases
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
van Rosendael AR, van den Hoogen IJ, Gianni U, Ma X, Tantawy SW, Bax AM, Lu Y, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Conte E, Marques H, de Araújo Gonçalves P, Gottlieb I, Hadamitzky M, Leipsic JA, Maffei E, Pontone G, Shin S, Kim YJ, Lee BK, Chun EJ, Sung JM, Lee SE, Virmani R, Samady H, Sato Y, Stone PH, Berman DS, Narula J, Blankstein R, Min JK, Lin FY, Shaw LJ, Bax JJ, Chang HJ
doi: 10.1001/jamacardio.2021.3055
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease
JAMA Cardiol.
Cannon CP, Khan I, Klimchak AC, Reynolds MR, Sanchez RJ, Sasiela WJ
doi: 10.1001/
Atrial Fibrillation
Quality of Life Following Initial Treatment of Atrial Fibrillation with Cryoablation Versus Drug Therapy Initial Treatment with Cryoablation or Drug Therapy
Heart Rhythm
Wazni O, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, Niebauer M, Makati K, Halperin B, Gauri A, Morales G, Shao M, Pouliot E, Kaplon RE, Nissen SE, STOP-AF First Trial Investigators.
doi: 10.1016/j.hrthm.2021.10.009
Cardiovascular Risk and DiseasesLipid-Lowering Drugs
Low-Density Lipoprotein Cholesterol and Drug Treatment to Lower Atherosclerotic Cardiovascular Disease Risk: Where Do We Stand?
JAMA Cardiol.
Lloyd-Jones DM
doi: 10.1001/
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study
JACC Cardiovasc Imaging.
Vaidya K, Arnott C, Martínez GJ, Ng B, McCormack S, Sullivan DR, Celermajer DS, Patel S
doi: 10.1016/
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering DrugsMyocardial InfarctionThrombosis and Stroke
Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
JAMA Cardiol.
Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P, van Hout B, Villa G, Qian Y, Somaratne R, Sabatine MS
doi: 10.1001/jamacardio.
Hypertension
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
Lancet.
Chow CK, Thakkar J, Bennett A, Hillis G, Burke M, Usherwood T, Vo K, Rogers K, Atkins E, Webster R, Chou M, Dehbi HM, Salam A, Patel A, Neal B, Peiris D, Krum H, Chalmers J, Nelson M, Reid CM, Woodward M, Hilmer S, Thom S, Rodgers A
doi: 10.1016/
Lipid-Lowering DrugsMyocardial Infarction
Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study
JACC Cardiovasc Imaging.
Räber L, Koskinas KC, Yamaji K, Taniwaki M, Roffi M, Holmvang L, Garcia Garcia HM, Zanchin T, Maldonado R, Moschovitis A, Pedrazzini G, Zaugg S, Dijkstra J, Matter CM, Serruys PW, Lüscher TF, Kelbaek H, Karagiannis A, Radu MD, Windecker S
doi: 10.1016/j.jcmg.2018.08.024.
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy
Circ Cardiovasc Imaging.
Kwon O, Kang SJ, Kang SH, Lee PH, Yun SC, Ahn JM, Park DW, Lee SW, Kim YH, Lee CW, Han KH, Park SW, Park SJ
doi: 10.1161/